http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
Emanuele Perrone,Ilaria Capasso,Tina Pasciuto,Alessandro Gioè,Salvatore Gueli Alletti,Stefano Restaino,Giovanni Scambia,Francesco Fanfani 대한부인종양학회 2021 Journal of Gynecologic Oncology Vol.32 No.3
Objective: The aim of this study is to analyze and draw the potential differences between therobotic-assisted surgery (RS) and the laparoscopy (LPS) in endometrial cancer staging. Methods: In this single-institution retrospective study we enrolled 1,221 consecutive clinicalstage I–III endometrial cancer patients undergone minimally invasive surgical staging. Wecompared patients treated by LPS and by RS, on the basis of perioperative and oncologicaloutcomes (disease-free survival [DFS] and overall survival [OS]). A sub-analysis of the high risk endometrial cancer population was performed in the 2 cohorts. Results: The 2 cohorts (766 treated by LPS and 455 by RS) were homogeneous in termsof perioperative and pathological data. We recorded differences in number of relapse/progression (11.7% in LPS vs. 7% in RS, p=0.008) and in number of deaths (9.8% in LPSvs. 4.8% in RS, p=0.002). Whereas, univariate and multivariate analyses according to DFSand OS confirmed that the surgical approach did not influence the DFS or the OS. In themultivariable analysis the association of the age and grading was significant for DFS and OS. In the sub-analysis of the 426 high risk EC patients (280 in LPS and 146 in RS) the univariateand the multivariate confirmed the influence of the age in DFS and OS, independently of theminimally invasive approach. Conclusions: In our large retrospective analysis, we confirmed that the RS and LPS havesimilar efficacy and safety for endometrial cancer staging also for the high-risk endometrialcancer patients.